Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.529 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.41.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.33 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.17.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.99.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
MJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.39.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.58.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.18.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LF.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDK.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LB.1.7.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.18.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.16.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LU.2ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-23068.4Japan
XBB.1.9.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23050.9China
HK.28NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23050.9China
B.1.160.22SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-23040.9China
B.1.1.487SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-23040.9China
XBUSChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-23040.9China
JC.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-23040.9China
B.1.558NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-23027.8US
B.1.1.163NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23021.9US
BA.2.59NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-23018.5US
B.1.1.272NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-23018.5US
XBB.4NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-23018.5US
B.31NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-23018.5US
B.1.494NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-22948.2US
B.50NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.494NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.165NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.554NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.243.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
A.2.5.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.450NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.268NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.344NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used